Biotech · Therapeutics deck
Therapeutics pitch decks from mechanism to milestones.
A therapeutics deck carries a lead program toward a value inflection point. Investors want the biology, the data and the plan, with every scientific claim precise.
Fixed prices. No calls: you brief us in writing and comment in writing.
Pipeline
Lead program heads into the clinic
Illustration only. Any figures are invented for this sample slide.
Who reads it
Life science investors, some specialists and some generalists, often with scientific advisers reviewing.
Turnaround
5 business days for a design rebuild; 3 business days for an audit.
How it differs
How a therapeutics deck differs from a general pitch deck
A general startup deck sells traction. A therapeutics deck sells a program that may have no revenue for years, so the evidence is scientific and the plan is a series of studies. It is read in two layers: a generalist checks the need, the milestone and the money, while a scientific adviser checks models, statistics and comparators. Value moves at data readouts and regulatory steps, so the raise must reach a named one with runway to spare. Patent scope and manufacturing are diligence items most general decks never carry.
Slide by slide
What goes in a therapeutics deck
- 01
Indication and need
Patients, standard of care and its limits.
- 02
Mechanism
One diagram a generalist can follow.
- 03
Lead program data
Results with study design, size and comparator.
- 04
Pipeline
Programs by stage.
- 05
Development plan
Next studies, regulatory path and timing.
- 06
Competitive landscape
Approved therapies and programs in development.
- 07
Intellectual property
Patent families and status.
- 08
Use of funds
Capital tied to named milestones.
The questions behind every slide
What readers of a therapeutics deck ask
Each answer names the slide or document where it belongs. If a question has no home in your deck, the reader will ask it in writing, or stop reading.
- 1
What is the target product profile, and how would it improve on the standard of care?
A target product profile slide, or a box on the indication slide, covering population, route, dosing and efficacy goal.
- 2
What is the next value inflection point, and does this round reach it with runway left?
The use of funds slide should name one milestone, its cost and the runway remaining after it.
- 3
Has this mechanism been tested in humans before, by anyone?
The competitive landscape slide, citing public sources and dated.
- 4
Which models support the data, and how well do they predict results in patients?
The lead program data slide should name the model, with the rationale in the scientific appendix.
- 5
Do you hold composition-of-matter claims, or only method-of-use?
The intellectual property slide, with a patent family table in the appendix confirmed by your patent counsel.
- 6
How will the drug be made, and by whom?
A manufacturing line on the development plan slide, with the plan in the appendix.
- 7
Has a freedom-to-operate review been done?
The intellectual property slide should state whether one exists, as your patent counsel describes it.
- 8
Which regulatory designations have you applied for or received?
The development plan slide, listing only those filed or granted, in wording your regulatory counsel approves.
Headline rewrites
Slide titles that say something.
A reader skims headlines first. A label tells them the topic; a sentence tells them the point. Bracketed figures are placeholders for your own numbers.
Before
Lead program
After
[Program] reduced [endpoint] by [X]% versus [comparator] in [model]
Before
Use of funds
After
$[X]M takes [program] through [milestone] with [X] months of runway to spare
Before
Mechanism
After
Blocking [target] stops [disease process] at its source, not downstream
What we fix
Faults we see in therapeutics deck drafts
Figures pasted from papers at unreadable size.
Results with no comparator.
Milestones without dates.
What you receive
Documents we produce
- Investor deck
- Non-confidential deck
- Scientific appendix
Every file is delivered editable, in PowerPoint, Google Slides or Keynote, with a PDF for sending. A therapeutics deck rebuild starts at $3,500; the full Raise Set with one-pager and teaser is $10,000.
Format
Length, versions and appendix
- Length
- Often 15 to 20 main slides, with a scientific appendix as long as the data needs.
- Send-ahead version
- Send the non-confidential version first. The full deck follows under a confidentiality agreement.
- Presented version
- Lead with the patient and the program. Keep the mechanism to one slide and go deeper only when the room asks.
What belongs in the appendix
- Full study designs and statistics
- Additional preclinical or clinical figures
- Patent family table
- Manufacturing and CMC plan
- Competitor program table with sources
- Advisor and key opinion leader biographies
Before you send it
Therapeutics deck checklist
- Every data slide states the model or population, the number of subjects and the comparator.
- Every redrawn figure is confirmed by your scientists in writing.
- Each milestone carries a period, such as a quarter or half-year.
- Pipeline stages match the development plan text.
- Competitor programs are cited from public sources and dated.
- Intellectual property statements are reviewed by your patent counsel.
- Forward-looking statement and confidentiality labels are in place.
- Confidential and non-confidential versions are saved and named separately.
Glossary
Terms used in a therapeutics deck
- Target product profile (TPP)
- A summary of the features a drug must have to meet patient needs and its development goals, such as population, dosing and efficacy.
- Investigational New Drug application (IND)
- The US FDA submission a sponsor makes before testing a new drug in people.
- Standard of care
- The treatment clinicians generally use today for a given condition.
- Value inflection point
- A milestone, such as a data readout, after which investors expect the program to be worth much more.
- CMC
- Chemistry, manufacturing and controls: how a drug is made, tested and kept consistent from batch to batch.
- Composition-of-matter patent
- A patent on the molecule or substance itself, as opposed to a particular use of it.
Your written brief
What to send us for a therapeutics deck
No call needed. Send what you have; missing items are listed in our written reply, and nothing is invented to fill a gap.
- 01Lead program data with study designs, subject numbers and comparators
- 02Original figures or source data for redrawing
- 03Target product profile, if written
- 04Development plan and regulatory strategy as your regulatory counsel describes them
- 05Patent family list from your patent counsel
- 06Competitive landscape notes with sources
- 07Budget by milestone and current runway
- 08Team and advisor biographies
Packages
Four packages, fixed prices.
Deck Audit
$1,500
3 business days
A written verdict on the deck you have, before you send it to anyone.
- Slide-by-slide notes inside your file
- The fixes that matter most, in order
- Story, numbers and design, each assessed
- The investor questions your deck leaves open
One deck, up to 20 slides. No redesign included.
Choose Deck AuditInvestor Finish
$3,500
5 business days
Your draft, rebuilt to investor standard. Design only.
- Up to 15 slides rebuilt
- Charts redrawn from your data
- Your brand applied throughout
- One written revision round
- Editable PowerPoint, Google Slides or Keynote
Design only: your wording and slide order stay as they are.
Choose Investor FinishFinish + Story
$6,500
8 business days
We restructure the argument, rewrite the headlines, then rebuild the deck.
- Up to 20 slides
- Narrative restructured from your draft and notes
- Headlines rewritten as full-sentence points
- Send-ahead PDF version
- Two written revision rounds
We work from your facts. No market research or financial modeling.
Choose Finish + StoryRaise Set
$10,000
12 business days
Everything a raise needs, in one matching set.
- Up to 30 slides plus appendix
- Investor one-pager
- Short teaser version for cold outreach
- Three written revision rounds
- All source files
No investor introductions, fundraising or legal advice.
Choose Raise SetNot included in any package: Calls or meetings · Market research · Financial modeling or valuation · Investor introductions · Fundraising, legal or securities advice. Extra slides and extra revision rounds are quoted in writing before we start them.
Questions, answered.
Who confirms the science?+
You do, in writing, slide by slide. We never alter data or restate conclusions.
How much does a pitch deck cost here?+
A written Deck Audit is $1,500. Investor Finish, a design rebuild of up to 15 slides, is $3,500. Finish + Story, with the argument restructured, is $6,500. Raise Set, up to 30 slides with a one-pager and teaser, is $10,000.
How long does it take?+
Three business days for an audit, five for Investor Finish, eight for Finish + Story and twelve for Raise Set, counted from payment and a complete brief.
Is there a call?+
No. No package includes a call or meeting. You brief us in writing and comment in writing.
What do I need to send?+
Your draft deck in any editable format, or notes if you chose a package with writing, plus a few lines on who will read it and what you are asking for.
How do I pay?+
By card, through a secure payment link we send once scope and delivery date are confirmed in writing.
More decks in Biotech
All 4 Biotech decksOther categories
- Real estate
- SaaS and software
- AI startups
- Fintech
- Healthcare
- Climate and energy
- Hardware and robotics
- Consumer brands
Pitch deck design for biotech companies: science, pipeline and milestones made clear for investors who are not all specialists. Fixed packages from $3,500.
Further reading
Sources we read when writing this page. General information only; not legal, tax or investment advice.
Have a draft? Send it today.
Choose a package, link your deck and write a few lines about who it is for. You get scope, a delivery date and a payment link in writing.